Skip to content
Governance Register

← US public companies

Juno Therapeutics, Inc.

SEC CIK 1594864 · JUNO · last insider filing 2018-03-07

Directors (from insider filings)

NameCapacity as filedFilings
Wilderotter Mary Agnes Director filed 2014 - 2018
Pien Howard H Director filed 2014 - 2018
Flatley JAY T Director filed 2017 - 2018
Nelsen Robert Director filed 2014 - 2018
Evnin Anthony B Director filed 2014 - 2018
Barron Hal Director filed 2014 - 2018
Bishop Hans Edgar Director · See Remarks filed 2014 - 2018
Daniel Thomas O Director filed 2015 - 2018
Klausner Richard Director filed 2014 - 2018
Vessey Rupert Director filed 2017 - 2017
Tessier-Lavigne Marc Director filed 2014 - 2016

Officers (from insider filings)

NameTitle as filedFilings
Cassidy Bernard J General Counsel and Secretary filed 2014 - 2018
Agarwal Sunil President of R & D filed 2017 - 2018
Harr Steve See Remarks filed 2014 - 2018
Azelby Robert See Remarks filed 2015 - 2018
LEE ANN L. EVP, Technical Operations filed 2017 - 2018
Levitsky Hyam See Remarks filed 2015 - 2017
Frohlich Mark W See Remarks filed 2014 - 2016

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.